title: Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial.
authors.affiliation: Stroke Trials Unit, Institute of Neuroscience, University of Nottingham, Clinical Sciences Building, City Hospital Campus, Nottingham NG7 2UH, UK.
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: England
authors.forename: Philip M W
authors.initials: PM
authors.lastname: Bath
authors.forename: Gillian M
authors.initials: GM
authors.lastname: Sare
authors.forename: Chamila
authors.initials: C
authors.lastname: Geeganage
authors.forename: Thierry
authors.initials: T
authors.lastname: Moulin
authors.forename: Desmond
authors.initials: D
authors.lastname: O'Neill
authors.forename: France
authors.initials: F
authors.lastname: Woimant
authors.forename: Hanne
authors.initials: H
authors.lastname: Christensen
authors.forename: Peter
authors.initials: P
authors.lastname: De Deyn
authors.forename: Didier
authors.initials: D
authors.lastname: Leys
authors.forename: E Bernd
authors.initials: EB
authors.lastname: Ringelstein
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002543:Cerebral Hemorrhage / Q000188:drug therapy / Q000473:pathology*; D002544:Cerebral Infarction / Q000188:drug therapy / Q000473:pathology*; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D020521:Stroke / Q000188:drug therapy* / Q000473:pathology*; D000078222:Tinzaparin; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D000078222:Tinzaparin; D001241:Aspirin